Femme-Tab ED 30/150
Levonorgestrel 150 µg and Ethinyloestradiol 30 µg tablets
Consumer Medicine Information
What is in this leaflet
Please read this leaflet carefully before you start using Femme-Tab ED 30/150. It will advise you about how to take Femme-Tab ED 30/150 properly and when to tell your doctor about health-related conditions. If you have any questions or need more advice, ask your doctor, professional health care provider or pharmacist.
What is Femme-Tab ED 30/150 used for and how does it work
Femme-Tab ED 30/150 is a combined oral contraceptive (often called "the Pill") consisting of 21 yellow to brownish active tablets and 7 red-brown inactive (placebo) tablets. Each round yellow to brownish film-coated tablet contains a small amount of two different female hormones. These are levonorgestrel (a progestogen) and ethinyloestradiol (an oestrogen). Because of the small amount of hormones, Femme-Tab ED 30/150 is considered to be a low-dose combined oral contraceptive preparation. The red-brown inactive tablets do not contain any active ingredients.
How does Femme-Tab ED 30/150 work?
Combined oral contraceptive Pills, such as Femme-Tab ED 30/150, provide one of the most effective reversible methods of contraception known. Usually, when Femme-Tab ED 30/150 is taken according to the instructions, the egg cells (normally released by the ovary each month) are prevented from maturing to the point where they can be fertilised. In addition, the cervical mucus remains thick, so it is more difficult for a man's sperm to enter the womb. Also, the lining of the womb is not prepared sufficiently for a fertilised egg to grow in.
What is Femme-Tab ED 30/150 used for?
Femme-Tab ED 30/150 is used to prevent pregnancy. Combined oral contraceptives are a very effective method of birth control. When taken correctly (without missing tablets) the chance of becoming pregnant is very low (approximately 1% per year). The failure rate may increase when tablets are missed or taken incorrectly.
Like other combined oral contraceptive pills, Femme-Tab ED 30/150 may also have non-contraceptive health benefits.
- Your period may be lighter and shorter. As a result, the risk of anemia may be lower. Your period pains may become less severe or may completely disappear.
- Some serious disorders have been reported to occur less frequently in users of "high-dose" oral contraceptive pills. These are benign breast disease, ovarian cysts, pelvic infections (pelvic inflammatory disease or PID), ectopic pregnancy (pregnancy in which the embryo implants outside of the womb) and cancer of the endometrium (lining of the womb) and ovaries. This may also be the case for "low-dose" pills such as Femme-Tab ED 30/150, but so far this has only been confirmed for endometrial and ovarian cancer.
Before you use Femme-Tab ED 30/150
Do not use Femme-Tab ED 30/150 if you have any of the conditions listed below. If any of these apply to you, tell your doctor before starting to use Femme-Tab ED 30/150. Your doctor may advise you to use a different type of hormonal contraception or an entirely different (non-hormonal) method of birth control.
You must not use Femme-Tab ED 30/150 if:
- you have, or have ever had a disorder affecting the blood circulation. In particular, those conditions relating to thrombosis. Thrombosis is the formation of a blood clot. This may occur in the blood vessels of the legs (deep vein thrombosis), the lungs (pulmonary embolism), the heart (heart attack), the brain (stroke), or other parts of the body. (See also the section later in this leaflet called "Femme-Tab ED 30/150 and thrombosis").
- you have or have ever had a stroke caused by a rupture of a blood vessel in the brain
- you have or have ever had a condition that may be a first sign of a heart attack (such as angina pectoris or chest pain) or stroke (such as transient ischemic attack or small reversible stroke)
- you have a history of migraine accompanied by visual symptoms or speech disability or weakness or numbness in any part of your body
- you have diabetes mellitus with blood vessel damage
- You or someone in your immediate family has or has had high blood levels of cholesterol or triglycerides (fatty substances)
- you have or have had pancreatitis (an inflammation of the pancreas) associated with high levels of fatty substances in your blood
- you have jaundice (yellowing of the skin) or severe liver disease, as long as liver function test results have not returned to normal
- you have or have had a cancer that may grow under the influence of sex hormones (e.g. cancer of the breast or the genital organs)
- you have or have had a benign or malignant liver tumour
- you have any unexplained vaginal bleeding
- you are pregnant or think you might be pregnant
- you are allergic (hypersensitive) to any of the ingredients of Femme-Tab ED 30/150
If any of these conditions appear for the first time while using Femme-Tab ED 30/150, stop taking it at once and consult your doctor. In the meantime, use non-hormonal contraceptive measures.
Tell your doctor if:
If Femme-Tab ED 30/150 is used in the presence of any of the conditions listed below or they appear for the first time, recur or worsen during treatment, you may need to be kept under close observation. Your doctor can explain this to you. You should tell your doctor if:
- you smoke
- you have diabetes
- you are overweight
- you have high blood pressure
- you have a heart valve disorder or a certain heart rhythm disorder
- you have an inflammation of your veins (superficial phlebitis)
- you have varicose veins
- anyone in your immediate family has had thrombosis, a heart attack or a stroke
- you suffer from headaches
- you suffer from epilepsy
- anyone in your immediate family has had breast cancer
- you have liver, kidney or gallbladder disease
- you have Crohn's disease or ulcerative colitis (chronic inflammatory bowel disease)
- you have systemic lupus erythematosus (SLE; a disease affecting the skin all over the body)
- you have haemolytic uremic syndrome (HUS; a blood clotting disorder causing failure of the kidneys)
- you have sickle cell disease
- you have a condition that occurred for the first time or worsened during pregnancy or previous use of sex hormones (e.g. hearing loss, a metabolic disease called porphyria, a skin disease called herpes gestationis, a neurological disease called Sydenham's chorea)
- you have or have had chloasma (yellowish-brown pigmentation patches on the skin, particularly of the face); if so, avoid too much exposure to the sun or ultraviolet radiation
- you have hereditary angioedema; taking estrogens may induce or exacerbate symptoms of angioedema. You should see your doctor immediately if you experience symptoms of angioedema such as swollen face, tongue and/or throat and/or difficulty swallowing or hives together with difficulty breathing.
What else you should know
Femme-Tab ED 30/150 does not protect against HIV infection (AIDS) or any other sexually transmitted disease.
In this leaflet, several situations are described where you should stop taking Femme-Tab ED 30/150, or where the reliability of Femme-Tab ED 30/150 may be decreased. In such situations you should not have sex or you should take extra non-hormonal contraceptive precautions, e.g. use a condom or another barrier method. Do not use rhythm or temperature methods. These methods can be unreliable because Femme-Tab ED 30 alters the usual changes in temperature and cervical mucus that occur during the menstrual cycle.
Femme-Tab ED 30/150 and thrombosis
Thrombosis is the formation of a blood clot which may block a blood vessel.
Thrombosis sometimes occurs in the deep veins of the legs (deep venous thrombosis). If this blood clot breaks away from the veins where it is formed, it may reach and block the arteries of the lungs, causing a so-called "pulmonary embolism". Deep venous thrombosis is a rare occurrence. The risk is highest during the first year a woman ever uses the Pill.
Venous thrombosis can develop whether or not you are taking the Pill. It can also happen if you become pregnant. The risk is higher in Pill users than in non-users, but not as high as during pregnancy.
Blood clots can also occur very rarely in the blood vessels of the heart (causing a heart attack) or the brain (causing a stroke). Extremely rarely, blood clots can occur in the liver, gut, kidney or eye.
Very occasionally a thrombosis may cause serious permanent disabilities or may even be fatal.
The risk of having a heart attack or stroke increases as you get older. It also increases the more you smoke.
When using Femme-Tab ED 30/150 you should stop smoking, especially if you are older than about 35 years of age.
If you develop high blood pressure while using Femme-Tab ED 30/150, you may be told to stop using it.
The risk of having deep venous thrombosis is temporarily increased as a result of an operation or immobilization (for example, when you have your leg or legs in plaster or splints). In women who use the Pill (such as Femme-Tab ED 30/150) the risk may be even higher. Tell your doctor you are using Femme-Tab ED 30 well in advance of any expected hospitalization or surgery. Your doctor may tell you to stop taking Femme-Tab ED 30/150 several weeks before surgery or at the time of immobilization. Your doctor will also tell you when you can start taking Femme-Tab ED 30/150 again after you are back on your feet.
If you notice possible signs of thrombosis, stop taking the Pill and consult your doctor immediately. (See also the section called "Stop taking Femme-Tab ED 30/150 and see your doctor immediately ")
Femme-Tab ED 30/150 and cancer
Breast cancer has been diagnosed slightly more often in women who use the Pill than in women of the same age who do not use the Pill. This slight increase in the numbers of breast cancer diagnoses gradually disappears during the course of the ten years after stopping use of the Pill. It is not known whether the difference is caused by the Pill. It may be that the women were examined more often, so that the breast cancer was noticed earlier.
In rare cases, benign, and even more rarely, malignant liver tumours have been reported in users of the Pill. These tumours may lead to internal bleeding. Contact your doctor immediately if you have severe pain in your abdomen.
The most important risk factor for cervical cancer is persistent human papilloma virus (HPV) infection. Some studies have indicated that long-term use of the Pill may further contribute to this increased risk, but there continues to be controversy about the extent to which this finding is attributable to other factors, e.g. cervical screening and sexual behaviour including use of barrier contraceptives.
Femme-Tab ED 30/150 and other medicines
Some medicines may stop Femme-Tab ED 30/150 from working properly. These include medicines used for the treatment of epilepsy (e.g. primidone, phenytoin, barbiturates, carbamazepine, oxcarbazepine, topiramate and felbamate); tuberculosis (e.g. rifampicin and rifabutin) and HIV infections (e.g. ritonavir and nevirapine); antibiotics (e.g. penicillins, tetracyclines and griseofulvin) for some other infectious diseases; and the herbal remedy St. John's wort (primarily used for the treatment of depressive moods).
The Pill may also interfere with the working of other medicines (e.g. medicines containing cyclosporin or the anti-epileptic lamotrigine).
Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines or herbal products, even those not prescribed. Always tell the doctor who prescribes Femme-Tab ED 30/150 which medicines you are already using. Also tell any other doctor or dentist who prescribes another medicine (or the dispensing pharmacist) that you use Femme-Tab ED 30/150. They can tell you if you need to take additional contraceptive precautions and if so, for how long.
Femme-Tab ED 30/150 and breast-feeding
Femme-Tab ED 30/150 is generally not recommended for use during breast-feeding. If you wish to take the Pill while breast-feeding, please seek the advice of your doctor.
Femme-Tab ED 30/150 and pregnancy
Femme-Tab ED 30/150 must not be used by women who are pregnant, or who think they may be pregnant. If you suspect that you are pregnant while you are using Femme-Tab ED 30/150 you should see your doctor as soon as possible.
How to use Femme-Tab ED 30/150 properly
Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information in this leaflet.
When you follow the directions correctly, the contraceptive protection provided by Femme-Tab ED 30/150 is continuous. This includes the week when you take the inactive tablets.
Additional contraceptive precautions are only required when special circumstances (e.g. forgetting tablets) reduce the reliability of the preparation.
Remember that Femme-Tab ED 30/150 has been prescribed for you personally. Do not share it with others.
When and how to take the tablets
The Femme-Tab ED 30/150 pack contains 21 round yellow to brownish active tablets and 7 red-brown inactive tablets. On the pack each tablet is marked with the day of the week on which it is to be taken. Take your tablet at about the same time each day, with some water if necessary. Follow the direction of the arrows until all 28 tablets have been taken. A period (the withdrawal bleed) should begin during the 7 days of taking the red-brown inactive tablets. Start taking your next pack on the very next day after you have completed your last pack even if your period continues. This means that you will always start new packs on the same day of the week, and also that you will have your withdrawal bleed on or about the same day each month.
Starting your first pack of Femme-Tab ED 30/150
When no hormonal contraceptive has been used in the past month
Start taking Femme-Tab ED 30/150 on the first day of your cycle, i.e. the first day of menstrual bleeding. Take your first tablet from the red section marked with that day of the week. For example, if your period starts on a Monday, take the tablet marked Monday from the red section of the pack. Then follow the days in order of the directional arrows. When you start taking Femme-Tab ED 30/150 your very first cycle may be shorter than usual. Additional non-hormonal contraceptive methods e.g. cap, diaphragm, condom, with spermicide, must be used for the next 14 days.
When changing from a combined Pill, or vaginal ring
You start taking Femme-Tab ED 30/150 the day after you take the last tablet from your present Pill pack (this means no tablet-free break). Take your first tablet from the red section marked with that day of the week. If your present Pill pack also contains inactive tablets you can start Femme-Tab ED 30/150 on the day after taking the last active tablet (if you are not sure which this is, ask your doctor or pharmacist).
Where you have used a vaginal ring, you should start using Femme-Tab ED 30/150 preferably on the day of removal. If you follow these instructions, it is not necessary to use an additional contraceptive method.
When changing from a progestogen-only Pill (minipill)
You can stop taking the minipill any day and start taking Femme-Tab ED 30/150 the next day, at the usual time. Take your first tablet from the red section marked with that day of the week. But make sure you also use an additional barrier contraceptive method for the first 14 days of tablet-taking when having intercourse.
When changing from an injectable, an implant or a progestogen-releasing intrauterine system (IUS)
Start using Femme-Tab ED 30/150 when your next injection is due or on the day that your implant or IUS is removed. Take your first tablet from the red section marked with that day of the week. But make sure you also use an additional barrier contraceptive method for the first 14 days of tablet-taking when having intercourse.
After having a baby
If you have just had a baby, your doctor may tell you to wait until after your first normal period before you start taking Femme-Tab ED 30/150. Sometimes it is possible to start sooner. Your doctor will advise you. If you are breast-feeding and want to take Femme-Tab ED 30/150, you should discuss this first with your doctor.
After a miscarriage or an abortion
Your doctor will advise you.
The following describes special circumstances that could alter the way you take Femme-Tab ED 30/150. In all situations where the reliability of Femme-Tab ED 30/150 is reduced (such as missing tablets) additional contraceptive precautions are required following the advice given below. This advice should also be followed in situations where other medicines may stop Femme-Tab ED 30/150 from working properly and in the case of vomiting or severe diarrhoea after taking Femme-Tab ED 30/150.
If you forget to take your tablets
If you forget to take a red-brown inactive tablet, take it as soon as you remember and continue to take the medicine as usual. As the inactive tables do not contain any active ingredients, you are still protected against pregnancy.
If you missed a yellow to brownish active tablet and remembered to take the missed tablet within 12 hours, you will be protected against pregnancy.
If you missed a yellow to brownish tablet for more than 12 hours, follow the detailed instructions bellow:
If you have been taking the yellow to brownish active tablets for 7 uninterrupted days before your missed tablet:
Take the missed tablet as soon as you remember and continue to take the medicine as usually, even if this means taking 2 tablets in one day.
After missing a yellow to brownish active tablet, the chance of pregnancy depends on when you missed the tablet. The risk of pregnancy is higher if you missed a tablet at the beginning or end of a pack.
If after taking your missed tablet you have less than 7 yellow to brownish tablets left in the blister pack, you should continue to finish the yellow to brownish tablets in that blister but skip the red-brown inactive tablets and start to take the yellow to brownish active tablets from the next pack corresponding to the correct day of the week.
This is the best way to maintain protection against pregnancy. You may not have a period until the end of the yellow to brownish tablets in the second blister pack. You may have spotting or breakthrough bleeding during the days of taking the active tablets.
If you have been taking the yellow to brownish active tablets for less than 7 uninterrupted days before your missed tablet:
Take the missed tablet as soon as you remember and continue to take the medicine as usually, even if this means taking 2 tablets in one day. You should also use additional barrier contraceptive precautions for the next 7 days:
Either don’t have sex or use a cap plus spermicide or a condom. Do not use the rhythm or temperature methods as extra contraceptive precautions. This is because oral contraceptives alter the usual menstrual cycle changes, such as changes in temperature and cervical mucus. If you have sex during that time, it is possible to get pregnant and you may need emergency contraception.
If you have had sex in the week before the missed tablet, it is possible to get pregnant. See your doctor or pharmacist for advice.
If you forget to take more than one yellow to brownish active tablet, see your doctor or pharmacist for advice.
Please refer to the below diagram for a summary of advice if you missed a yellow to brownish active tablet. Please ask your doctor or pharmacist if you have any questions regarding how to take this medicine.
If you vomit or have severe diarrhoea after taking Femme-Tab ED 30/150
If you vomit or have severe diarrhoea within 3 to 4 hours after taking your Femme-Tab ED 30/150 active tablets, the active ingredients may not have been completely absorbed. This is like missing a tablet. Therefore, follow the advice for missed tablets. If vomiting or diarrhoea occurs while taking the inactive tablets, this does not have an influence on the contraceptive reliability.
If you are taking medicines that affect Femme-Tab ED 30/150
Some medicines may stop Femme-Tab ED 30/150 from working properly. These medicines are listed in an earlier section. For the time that you are taking the medicine and for the next 7 days follow the advice for missed tablets. If you are taking rifampicin, or you are taking these medicines continuously, your doctor will advise you on the length of time you need to take extra contraceptive precautions.
If you want to delay a period
You can delay your period if you miss out the red-brown inactive tablets and go straight to the yellow to brownish active tablets in the red section of your next blister pack. Continue with this pack until this pack is empty. Your period will start while you are taking the red-brown inactive tablets in the next pack. You may have some breakthrough bleeding or spotting while you are taking the yellow to brownish active tablets.
If you want to change the starting day of your period
If you take your tablets as directed, you will have your period on about the same day every 4 weeks. If you want to change this, just shorten (never lengthen) the duration of taking the red-brown inactive tablets. For example, if your period usually starts on a Friday and in future you want it to start on Tuesday (3 days earlier) you should start your next pack 3 days sooner than you usually do, discard the 3 remaining red-brown tablets of your previous pack and then continue with the next pack without having a break between the packs. If you make the duration of taking the inactive tablets very short (e.g. 3 days or less), you may not have bleeding during the break. You may have some breakthrough bleeding or spotting during the use of the next pack.
If you have unexpected bleeding
As with other Pills, for the first few months, you can have irregular vaginal bleeding (spotting or breakthrough bleeding) with Femme-Tab ED 30/150 between your periods. You may need to use sanitary protection, but continue to take your tablets as normal. Irregular vaginal bleeding usually stops once your body has adjusted to Femme-Tab ED 30/150 (usually after about 3 tablet-taking cycles). If it continues, becomes heavy or starts again, tell your doctor.
If you have missed a period
If you have taken all of your tablets at the right time, and you have not vomited, had severe diarrhoea or used other medicines, then you are very unlikely to be pregnant. Continue to take Femme-Tab ED 30/150 as usual.
If you miss your period twice in a row, you may be pregnant. Tell your doctor immediately. Do not start the next pack of Femme-Tab ED 30/150 until your doctor has checked that you are not pregnant.
When you want to stop taking Femme-Tab ED 30/150
You can stop taking Femme-Tab ED 30/150 at any time you want. If you stop because you want to get pregnant, it is generally recommended that you wait until you have had a natural period before trying to conceive. This helps you to work out when the baby will be due.
If you do not want to become pregnant, ask your doctor about other methods of birth control.
There have been no reports of serious harmful effects from taking too many Femme-Tab ED 30/150 tablets at one time. If you think that you or anyone else may have taken too much Femme-Tab ED 30/150, telephone your doctor or the Poisons Information Centre (13 11 26 in Australia) for advice, or go to the Emergency Department at your nearest hospital.
Do this even if there are no signs of discomfort or poisoning. You may need medical attention.
While using Femme-Tab ED 30/150
Things you must do:
If you vomit within 3 to 4 hours or have severe diarrhoea after taking a yellow to brownish active tablet, the active ingredients may not have been completely absorbed. This should be treated as missing a tablet. Follow the advice above for missed tablets.
Femme-Tab ED 30/150 does not protect you from sexually transmitted diseases (STDs), such as HIV-AIDS, Chlamydia, genital herpes, genital warts, gonorrhoea, hepatitis B, human papilloma virus and syphilis. You will need additional barrier contraceptives (e.g. condoms) to protect yourself from STDs.
Have regular check ups with your doctor. When you are using Femme-Tab ED 30/150, your doctor will tell you to return for regular check-ups, including a pap smear test. Your doctor will advise how often you need to take the test.
Stop taking Femme-Tab ED 30/150 and see your doctor immediately:
- if you get a blood clot, heart attack or stroke. Warning signs for a blood clot, heart attack or stroke to look out for are:
– an unusual cough
– severe pain in the chest which may reach the left arm
– any unusual, severe, or prolonged headache or migraine attack
– partial or complete loss of vision, or double vision
– slurring or speech disability
– sudden changes to your hearing, sense of smell, or taste
– dizziness or fainting
– weakness or numbness in any part of your body
– severe pain in your abdomen
– severe pain or swelling in either of your legs
- if you become pregnant while taking the medicine
- if you miss your period twice in a row. You may be pregnant. Do not start the next pack of Femme-Tab ED 30/150 until your doctor has checked that you are not pregnant
Tell your doctor:
- if you develop high blood pressure while taking the medicine. You may be advised to stop taking it.
- if you have unexpected bleeding and it continues, becomes heavy, or occurs again. When taking this pill for the first few months, you can have irregular vaginal bleeding (spotting or breakthrough bleeding) between your periods. You may need to use sanitary protection, but continue to take your tablets as usual. Irregular vaginal bleeding usually stops once your body has adjusted to the Pill, usually after about 3 months.
- if you have any concerns for a missed period. It is very unlikely to be pregnant if you have been taking the medicine correctly, provided that you have taken the yellow to brownish active tablets at the right time, you have not been taking any other medicines that may interfere with Femme-Tab ED 30/150, and you have not vomited for had severe diarrhoea during the cycle.
Tell your doctors, pharmacists, dentists, surgeons or anaesthetists that you are taking Femme-Tab ED 30/150:
- Before you have any treatments or tests
- Before you start any new medicines
- Before any surgeries. The risk of having deep venous thrombosis is temporarily increased as a result of an operation or immobilisation (for example, when you have your leg or legs in plaster or splints). The excess risk of thrombosis is highest during the first year a woman takes a combined oral contraceptive. Your doctor may tell you to stop taking the medicine several weeks before surgery, or at the time of immobilisation, and when you can start taking the medicine again.
Things you must not do:
- Do not use Femme-Tab ED 30/150 for other purposes unless advised by your doctor
- Do not give your medicine to anyone else
- Do not stop taking your medicine or change the dosage without checking with your doctor. You may become pregnant if you are not using any other contraceptive and you stop taking Femme-Tab ED 30/150, or do not take a tablet every day.
Tell your doctor if you notice any unwanted side effects, especially if severe or persistent, or if there is a change in your health that you think might be caused by Femme-Tab ED 30/150.
All medicines can have side effects. Some are serious, most of them are not. Do not be alarmed by the following lists of the side effects. You may not experience any of them.
There is a risk of developing venous thromboembolism and arterial thromboembolism with use of this product. The degree of risk associated with developing these conditions will depend on your familial history and personal circumstances. Your doctor will discuss these risk factors with you.
More common side effects
These are usually mild and lessen with time.
If you notice any of the following side effects and have concerns or questions, tell your doctor or pharmacist:
- breast tenderness or pain
If you experience any of the following and they worry you, see your doctor:
- weight gain
Very serious but rare side effects
If you experience any of the following tell your doctor immediately, or go to the Emergency Department at your nearest hospital. You may need urgent medical attention or hospitalisation.
- possible signs of a thrombosis:
– chest pain, which may increase with deep breathing.
– breathlessness and/or difficulty breathing
– painful swelling in your leg(s)
– weakness, numbness or bad ‘pins and needles’ of an arm or leg
– pain or tenderness in the leg which may be only felt when standing or walking.
– increased warmth in the affected leg; red or discoloured skin on the leg.
– severe, sudden stomach pains
– severe lightheadedness or dizziness
– rapid or irregular heartbeat
– a bad fainting attack or you collapse
– unusual headaches or migraines that are worse than usual
– sudden problems with your speech or eyesight, or motor coordination.
– sudden coughing which may result in you coughing up blood
– pain, discomfort, pressure, heaviness, sensation of squeezing or fullness in the chest, arm, or below the breastbone.
– discomfort radiating to the back, jaw, throat, arm, stomach
– feeling of being full, having indigestion or choking
– sweating, nausea, vomiting or dizziness
- jaundice (yellowing skin or yellowing eyes)
- breast lumps
- unexplained vaginal bleeding.
After taking Femme-Tab ED 30/150
Do not use after the expiry date stated on the package.
Store all medicines properly and keep them out of reach of children.
Keep the medicine in the original packaging in a cool and dry place below 25°C
Do not take the tablets out from the blister until it is time to take them.
Do not store the medicine in the bathroom, near a sink or on a window sill.
Do not leave the medicine in the car.
If your doctor tells you to stop taking this medicine or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.
Return any unused medicine to your pharmacist.
What Femme-Tab ED 30/150 looks like
Femme-Tab ED 30/150 comes in a box containing 1, 3 or 4 blister packs. AUST R 170388
Each blister pack contains 21 yellow to brownish active tablets and 7 red-brown inactive tablets.
The blister is marked with the days of the week for each tablet.
Levonorgestrel 150 µg
Ethinyloestradiol 30 µg
Tablets also contain:
Each yellow to brownish active tablet also contains:
Lactose monohydrate, maize starch, gelatine, magnesium stearate, hypromellose (3cps), macrogol 4000, titanium dioxide (E171), and iron oxide yellow (E172)
Each red-brown inactive tablet contains:
Lactose monohydrate, maize starch, gelatine, magnesium stearate, hypromellose (3cps), macrogol 4000, titanium dioxide (E171), and iron oxide red (E172)
AFT Pharmaceuticals Pty. Ltd.
113 Wicks Road North Ryde
Date of Preparation
13 August 2015
Published by MIMS September 2017